%0 Journal Article
%T Generation and characterization of an inducible transgenic model for studying mouse esophageal biology
%A Sabrina Roth
%A Patrick Franken
%A Kim Monkhorst
%A John Kong a San
%A Riccardo Fodde
%J BMC Developmental Biology
%D 2012
%I BioMed Central
%R 10.1186/1471-213x-12-18
%X First, we generated a transgenic mouse model expressing the reverse tetracycline transactivator rtTA2-M2 under control of the promoter (ED-L2) of the Epstein-Barr virus (EBV) gene encoding the latent membrane protein-1 (LMP-1). The newly generated ED-L2-rtTA2-M2 (ED-L2-rtTA) mice were then bred with the previously developed tetO-HIST1H2BJ/GFP (tetO-H2B-GFP) model to assess inducibility and tissue-specificity. Expression of the H2B-GFP fusion protein was observed upon doxycycline induction but was restricted to the terminally differentiated cells above the basal cell layer. To achieve expression in the basal compartment of the esophagus, we subsequently employed a different transgenic model expressing the reverse transactivator rtTA2S-M2 under the control of the ubiquitous, methylation-free CpG island of the human hnRNPA2B1-CBX3 gene (hnRNP-rtTA). Upon doxycycline administration to the compound hnRNP-rtTA/tetO-H2B-GFP mice, near-complete labeling of all esophageal cells was achieved. Pulse-chase experiments confirmed that complete turnover of the esophageal epithelium in the adult mouse is achieved within 7¨C10£¿days.We show that the esophagus-specific promoter ED-L2 is expressed only in the differentiated cells above the basal layer. Moreover, we confirmed that esophageal turn-over in the adult mouse does not exceed 7¨C10£¿days.
%K Mouse
%K Esophagus
%K Turnover rate
%K Promoter
%K ED-L2
%K Doxycycline inducible
%U http://www.biomedcentral.com/1471-213X/12/18/abstract